PACE-CME

Introduction: The evolving role of triglycerides

Introduction The evolving role of triglycerides
RestartResume
10' education - Nov. 15, 2020 - Prof. Peter LIbby, MD
  • Overview

    Prof. Libby gives an introduction to the symposium about the evolving role of triglycerides in residual CV risk, that was held during the virtual ESC 2020 congress.

  • Educational information

    This lecture by prof. Peter Libby was part of an accredited symposium "Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides" held during the virtual ESC Congress 2020.

  • Faculty

    Prof. Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital (Boston, MA, VS) and the Mallinckrodt Professor of Medicine at Harvard Medical School (Boston, MA, VS).

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

    Funding

    Funding for this educational program was provided by an unrestricted educational grant from Amarin.

    Click here for the meeting report

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free